Jacqueline W Pierce

Title: Jacqueline W. Pierce: Innovator in Biomarker Research

Introduction

Jacqueline W. Pierce is a notable inventor based in Wellesley, MA (US). She has made significant contributions to the field of biomarker research, particularly in the context of HDAC mediated cell proliferative disorders. Her work focuses on developing methods for predicting treatment responses based on specific protein and transcription biomarkers.

Latest Patents

Jacqueline W. Pierce holds a patent titled "Methods for predicting treatment response based on the expression profiles of protein and transcription biomarkers." This invention describes novel biomarkers that are useful for risk assessment, screening, prognosis, and the selection and monitoring of therapy for HDAC mediated cell proliferative disorders. The invention identifies three particular proteins whose expression patterns are strongly predictive of a patient's treatment outcome, such as non-responsiveness to SAHA. The expression profile, whether in nucleic acid expression, protein expression, or other formats, aids in identifying patients with specific HDAC mediated cancers who are likely to be non-responsive to SAHA-based therapy, thus guiding them towards alternative treatments.

Career Highlights

Jacqueline W. Pierce is currently associated with Merck Sharp & Dohme Corp., where she continues her research and development efforts in the field of biomarker discovery and application. Her innovative work has the potential to significantly impact patient care and treatment strategies in oncology.

Collaborations

Jacqueline has collaborated with esteemed colleagues such as Valeria R. Fantin and Andrey Loboda, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Jacqueline W. Pierce is a pioneering inventor whose work in biomarker research is paving the way for improved treatment strategies in cancer therapy. Her contributions are vital for advancing personalized medicine and enhancing patient outcomes.